ArticleLaryngoscope investigative otolaryngology2025
"Who Needs More Help?": The Predictors of Continued Smoking in Laryngeal Cancer Patients at Different Periods.
Article in Laryngoscope investigative otolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- "Who Needs More Help?": The Predictors of Continued Smoking in Laryngeal Cancer Patients at Different Periods.Laryngoscope investigative otolaryngology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to identify factors associated with continued smoking before and after treatment in laryngeal cancer (LC) patients. Methods: This retrospective study included 108 patients, evenly distributed into three groups based on primary treatment: radiotherapy (RT)/chemoradiotherapy, transoral laser surgery (TOLS), and open-partial laryngectomy (OPL). Patients who remained abstinent from smoking for at least 6 months at the 1st year were accepted as ex-smokers. The relationship between patients' smoking status and demographic characteristics, disease- and treatment-related parameters, and data obtained via self-questionnaires at pre-treatment, the 1st month, and 1st year post-treatment follow-ups was analyzed statistically. Results: Patient age, education level, smoking intensity, perceived disease seriousness, importance of smoking cessation, information satisfaction, pre-treatment quality of life (QoL), and treatment method differ between LC patients who quit and those who continue smoking. Potential negative predictors for pre-treatment cessation and ex-smoker status include advanced age and age > 64.5 years, lower education level, advanced and > 47 pack-years smoking consumption, low perceived disease seriousness, low importance on cessation, poor pre-treatment QoL, and less invasive treatment. Notably, cessation before treatment might be the strongest predictor of being an ex-smoker, with an OR of 47.6 ( Conclusion: This study identified the potential predictors of smoking cessation in the post-diagnosis period, and might facilitate the detection of high-risk patients who need intensive smoking cessation interventions. Level of Evidence: Level 3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.